临床因素对低肾小球滤过率患者静脉碘对比剂低渗对比剂致肾毒性风险的影响
该回顾性假设生成研究纳入1112例eGFR 30-44 mL/min/1.73 m2及86例eGFR<30 mL/min/1.73 m2且未透析的慢性肾脏病IIIb-V期患者,经1:1倾向性评分匹配评估平扫或增强CT后急性肾损伤。静脉低渗对比剂仅在eGFR<30 mL/min/1.73 m2患者中为独立危险因素(OR 3.96,95%CI 1.29-12.21,p=0.016),eGFR 30-44 mL/min/1.73 m2患者中合并心血管疾病者对比剂肾毒性风险显现(p=0.015,需伤害人数11例),其他因素如糖尿病未增加风险。作者指出需进一步研究确认这些探索性结果是否为真实关联。
要点
- eGFR<30 mL/min/1.73 m2患者静脉低渗对比剂为CT后急性肾损伤独立危险因素(OR 3.96)。
- eGFR 30-44 mL/min/1.73 m2患者中,合并心血管疾病者对比剂肾毒性风险显现,需伤害人数11例。
- 糖尿病、年龄>60岁、高血压、袢利尿剂、氢氯噻嗪及心血管疾病在eGFR<30 mL/min/1.73 m2患者中未显著改变对比剂肾毒性风险(p=0.096-0.832)。
核心结论
- 静脉低渗对比剂在eGFR<30 mL/min/1.73 m2患者中观察到对比剂肾毒性;在eGFR 30-44 mL/min/1.73 m2患者中,单用低渗对比剂未观察到对比剂肾毒性,但合并心血管疾病时观察到;其他历史认为增加对比剂肾毒性风险的因素(如糖尿病)未增加风险。
研究设计与样本
- 回顾性假设生成研究,采用1:1倾向性评分匹配,纳入1112例eGFR 30-44 mL/min/1.73 m2患者及86例eGFR<30 mL/min/1.73 m2且未透析患者,评估平扫或增强CT后急性肾损伤,采用逐步多变量逻辑回归分析。
诊断标准与关键数值
- 静脉低渗对比剂在eGFR<30 mL/min/1.73 m2患者中为CT后急性肾损伤独立危险因素,OR 3.96(95%CI 1.29-12.21),p=0.016。
- 在eGFR 30-44 mL/min/1.73 m2患者中,静脉低渗对比剂与CT后急性肾损伤无显著关联(p=0.24)。
- 在eGFR<30 mL/min/1.73 m2患者中,所测协变量未显著改变对比剂肾毒性风险(p=0.096-0.832)。
- 在eGFR 30-44 mL/min/1.73 m2患者中,合并心血管疾病者对比剂肾毒性风险显现(p=0.015;低渗对比剂需伤害人数=11例),其他协变量无显著影响(p=0.108-0.822)。
临床应用与阅片要点
- 对于eGFR<30 mL/min/1.73 m2且未透析患者,静脉低渗对比剂为CT后急性肾损伤独立危险因素,OR 3.96(95%CI 1.29-12.21)。
- 对于eGFR 30-44 mL/min/1.73 m2患者,合并心血管疾病时对比剂肾毒性风险显现(p=0.015;需伤害人数=11例)。
- 其他历史认为增加对比剂肾毒性风险的因素(如糖尿病)未增加风险;作者指出需进一步研究确定这些探索性结果是否为真实关联。
局限性
- 原文为回顾性假设生成研究。
- 作者指出需进一步研究以确定这些探索性结果是否为真实关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to explore whether clinical factors historically associated with contrast material-causative kidney injury (contrast-induced nephrotoxicity [CIN]) increase risk after use of IV iodinated low-osmolality contrast material (LOCM) in patients with stage IIIb-V chronic kidney disease. MATERIALS AND METHODS. In this retrospective hypothesis-generating study, 1:1 propensity score matching was used to assess post-CT acute kidney injury (AKI) after unenhanced or contrast-enhanced CT in patients with stable estimated glomerular filtration rate (eGFR; 1112 patients with an eGFR = 30-44 mL/min/1.73 m2 and 86 patients with an eGFR < 30 mL/min/1.73 m2 and no dialysis). Historical risk factors including diabetes mellitus, age more than 60 years, hypertension, loop diuretic use, hydrochlorothiazide use, and cardiovascular disease were evaluated for modulation of CIN risk. Stepwise multivariable logistic regression was performed. RESULTS. Overall IV LOCM was an independent risk factor for post-CT AKI in patients with an eGFR of less than 30 mL/min/1.73 m2 (odds ratio, 3.96 [95% CI, 1.29-12.21]; p = 0.016) but not in those with an eGFR of 30-44 mL/min/1.73 m2 (p = 0.24). In patients with an eGFR of less than 30 mL/min/1.73 m2, the tested covariates did not significantly modify the risk of CIN (p = 0.096-0.832). In patients with an eGFR of 30-44 mL/min/1.73 m2, risk of CIN emerged in those with cardiovascular disease (p = 0.015; number needed to harm from LOCM = 11 patients); the other tested cofactors had no significant effect (p = 0.108-0.822). CONCLUSION. CIN was observed when eGFR was less than 30 mL/min/1.73 m2. In those with an eGFR of 30-44 mL/min/1.73 m2, CIN was not observed with LOCM alone but was observed in the presence of cardiovascular disease. Other cofactors historically thought to increase CIN risk (e.g., diabetes mellitus) did not increase risk of CIN. Further study is needed to determine whether these exploratory results are true associations.
引用
- Ellis JH, Khalatbari S, Yosef M, et al. Influence of Clinical Factors on Risk of Contrast-Induced Nephrotoxicity From IV Iodinated Low-Osmolality Contrast Material in Patients With a Low Estimated Glomerular Filtration Rate. AJR Am J Roentgenol. 2019. PMID: 31268731. doi:10.2214/AJR.19.21424
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。